GENE ONLINE|News &
Opinion
Blog

BIO
BIO 2022: Options for Raising Capital in a Down Market
2022-08-01
South Korea’s Biotech Industry:Trends, Landscape, and Clusters Overview
2022-08-01
How the Greater Tokyo Region Could Be the Next Promising Biocommunity
2022-07-19
Taiwan’s Biotech Industry Shines at the 2022 BIO International Convention
2022-06-24Partner
BIO 2022: Challenges in Developing Cell and Gene Therapies
2022-06-23
BIO 2022: San Diego Biotechs
2022-06-20
Over 50 Taiwan Organizations to Present at 2022 BIO International Convention
2022-06-08Partner
Top Highlights of BIO Asia-Taiwan 2020
2020-07-29Partner
Part I Highlights of BIO Asia-Taiwan 2020 (Day 1): The Effect of COVID-19 on Global Biotech Industry
2020-07-22Partner
BIO Asia-Taiwan 2019 – Biotech as the Next Growth Engine for Asia
2019-07-26
Asian Biotechnology Conference BIO ASIA to be held in Taiwan for the first time
2019-01-15
BIO
BIO International Convention Celebrating its 25th Anniversary in Boston
2018-06-06
LATEST
Axsome’s AXS-05 Achieves Endpoints In Alzheimer’s Agitation Trial
2022-11-29
Spectrum to Cut 75% of Staff and NSCLC Program Following CLR
2022-11-28
Full-Life Technologies to Acquire Focus-X Therapeutics, Bolstering Peptide-Focused Radiopharmaceutical Pipeline
2022-11-28
Medeologix Acquires Three Silicon Valley Medical Device CDMO Companies and Establishes One-Stop Shop Mass Production Facilities in Taiwan
2022-11-28
GenFleet Therapeutics to Present Data from Phase I Trial of GFH009 Monotherapy at the 2022 Annual Meeting of American Society of Hematology (ASH)
2022-11-28
Everest’s Renal Drug Gets Placed On Fast Track For Approval In Taiwan And Korea
2022-11-28
Canada Authorizes Roche’s Polivy as First-Line Lymphoma Treatment
2022-11-27
EVENT
2022-12-01
BIOCHINA 2022
Online
2022-12-10
64TH ASH ANNUAL MEETING & EXPOSITION
New Orleans, USA
2022-12-14
BIOHK2022
Hong Kong, China
2023-01-07
7th Asia Microbiome Conference
Taipei, Taiwan
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!